Target intelligence / Profile preview

Aerobic Gram-negative bacterium

Molecular classification
Other (Bacterial classification), Not applicable to standard molecular families like "Receptor" or "Enzyme"
01

Overview

Aerobic gram-negative bacteria are a diverse group of rod-shaped or spherical prokaryotes that require oxygen for growth. They possess an inner cytoplasmic membrane, a thin peptidoglycan layer, and an outer membrane containing lipopolysaccharide endotoxins. This unique envelope structure confers increased resistance to many antibiotics compared with gram-positive organisms. Clinically important genera include Neisseria (N. gonorrhoeae, N. meningitidis), Moraxella (M. catarrhalis), Escherichia (E. coli), Klebsiella (K. pneumoniae), Pseudomonas (P. aeruginosa), Salmonella (S. enterica) among others. These bacteria can cause serious infections such as pneumonia, urinary tract infections, sepsis, meningitis, gastroenteritis and more—often with high morbidity due to their ability to evade host defenses via their capsule and outer membrane structures. Because "aerobic gram-negative bacterium" refers broadly to any member of this category rather than one defined molecule or protein target used in drug discovery/therapeutics research contexts—and because it encompasses hundreds of different species—it should not be considered an appropriate entry for structured therapeutic targeting databases. "Aerobic gram‐negative cocci are sphere‐shaped bacteria that require oxygen... Pathogenic strains can cause gastrointestinal inflammation... kidney damage... Different strains can cause salmonellosis... diarrhea... typhoid fever." "Gram‐negative bacteria have an inner cell membrane ... thin peptidoglycan layer ... outer membrane containing lipopolysaccharides ... Porins exist in the outer membrane..." "Gram‐negative bacterial infections include ... gastroenteritis ... pneumonia ... peritonitis ... urinary tract infections … bloodstream infections … wound or surgical site infections … meningitis." If you need information about a specific genus/species within aerobic gram-negative bacteria—or about particular molecular targets found within these organisms—please specify further so I can provide more targeted data!

Other names
Aerobic Gram-negative bacteriaAerobic Gram-negative bacilliAerobic Gram-negative cocci
02

Mechanism of action

Drugs act by: Inhibiting cell wall synthesis (e.g., beta-lactams); Disrupting protein synthesis (e.g., aminoglycosides); Inhibiting DNA gyrase/topoisomerase IV (e.g., fluoroquinolones); Disrupting outer membrane integrity (e.g., polymyxins). (Mechanisms depend on drug class and specific bacterial targets.)

03

Biological functions

Cellular respiration (aerobic metabolism)Pathogenesis (in some species)Immune evasionOther general bacterial functions
04

Disease associations

Infection (including pneumonia, urinary tract infections, meningitis, gastroenteritis)SepsisOther infectious diseases
05

Safety considerations

Endotoxin release causing severe immune response/sepsis when killed rapidly by antibioticsHigh rates of antibiotic resistance among many members of this group—therapeutic failure risk is significantSome are opportunistic pathogens in immunocompromised patients
06

Interacting drugs

Aminoglycosides

4 more in the full profile.

07

Biomarkers

Gram stain result ("Gram negative")Nucleic acid amplification tests for species identificationCulture characteristicsLipopolysaccharide detection in some diagnostic assays

Beyond the preview

Go deeper on Aerobic Gram-negative bacterium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aerobic Gram-negative bacterium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call